Beta test rollout. This site is in community QA — please send feature requests, bug reports and data corrections on the Feedback page or on GitHub.

Home
    Disclaimer
    4-AcO-DALT molecular structure

    4-AcO-DALT Stats & Data

    4acodalt
    NPS DataHub
    MW298.38
    FormulaC18H22N2O2
    CAS1445751-71-2
    IUPAC[3-[2-[bis(prop-2-enyl)amino]ethyl]-1~{H}-indol-4-yl] acetate
    SMILESC=CCN(CC=C)CCc1cnc2cccc(OC(C)=O)c12
    InChIKeyWRHFDIBXZYYCHO-UHFFFAOYSA-N
    2020/5.1 Indol-3-alkylamine; 2021/5.1 Indol-3-alkylamine; 2022/5.1 Indol-3-alkylamine
    Chemical Class Substituted tryptamine
    Psychoactive Class Psychedelic

    Effect Profile

    Curated + 5 Reports
    Psychedelic 2.8

    Moderate body load with mild visuals, low headspace

    Visual Intensity×3
    4
    Headspace Depth×3
    2
    Auditory Effects×1
    0
    Body Load / Somatic Effects×1
    6

    Duration Timeline

    Bluelight
    Onset Comeup Peak Offset After Effects
    Oral
    30 minutes - 1.5 hours
    5.0-9.0 hours
    1.0-8.0 hours
    Total: 5-9 hours
    Smoked
    30 minutes - 1.5 hours
    5.0-9.0 hours
    1.0-8.0 hours
    Total: 5-9 hours

    Tolerance & Pharmacokinetics

    drugs.wiki

    Tolerance Decay

    Full tolerance 1h Half tolerance 10d Baseline ~14d

    Cross-Tolerances

    LSD
    Psilocybin
    Psilocin
    Mescaline
    DMT
    5-MeO-DMT
    2C-B
    2C-E

    Experience Report Analysis

    Erowid
    8 Reports
    5 Single-substance
    2007–2015 Date Range
    6 With Age Data
    7 Effects Detected

    Demographics

    Gender Distribution

    Too few reports for a chart: gender is known from 8 reports, and a split is drawn only from 20 reports or more. Counts are shown instead. Why 20?

    • Male 5 of 8
    • Not Specified 1 of 8
    • Female 2 of 8

    Age Distribution

    Reports Over Time

    Effect Analysis

    Erowid

    Effects aggregated from 5 experience reports (5 single-substance Erowid)

    5 Reports
    7 Effects Detected
    6 Positive
    1 Adverse
    0 Neutral

    Effect Sentiment Distribution

    Confidence Distribution

    Each bar is the share of reports mentioning the effect; its whisker, and the band on the rows below, is the 95% interval: where the share could plausibly be with other reports of the same kind.

    Too few reports for bars: these effects come from 5 single-substance Erowid reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    Positive Effects 6

    Visual Distortions 5 of 5 70%
    Music Enhancement 4 of 5 70%
    Closed-Eye Visuals 3 of 5 70%
    Color Enhancement 3 of 5 70%
    Euphoria 3 of 5 70%
    Empathy 3 of 5 70%

    Adverse Effects 1

    Nausea 3 of 5 70%

    Form / Preparation

    Most common forms and preparations, as a share of the 2 reports that give one

    Too few reports for bars: these forms come from 2 reports, and a bar is drawn only from 20 reports or more. With fewer, a percentage cannot tell a common effect from a rare one. Counts are shown instead. Why 20?

    • Powder / Crystals 2 of 2
    ← Back to 4-AcO-DALT